Macrophages play an important role in the peripheral nerve degeneration-regeneration process by producing cytokines and stimulating Schwann cells to proliferate and to play the role of phagocytes. In the process of macrophage recruitment from the peripheral vasculature, macrophage migration inhibitory factor (MIF) is considered to play a pivotal role to concentrate macrophages at inflammatory loci. In our previous reports, we demonstrated the presence of MIF in the peripheral nervous system, where Schwann cells were the potential sources of MIF protein in peripheral nerves and MIF mRNA expression was up-regulated after axotomy. However, the precise pathophysiological functions of MIF in nerve regeneration remained to be elucidated. In the present study, we locally administered anti-MIF antibodies into regenerating rat sciatic nerves using the silicone chamber model, and the effect of anti -MIF antibody administration on nerve regeneration was assessed using a pinch reflex test and antineurofilament immunohistochemical staining. Moreover, we carried out a terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) assay and immunohistochemical analysis of the damaged nerve segments with regard to apoptosis-relat ed proteins such as p53 to evaluate the effects of anti-MIF antibodies on apoptosis during the regeneration process.
axons in anti -MIF antibody -treated nerves was significantly less than that in the control nerve at week 4 after surgery (Fig. 1B) . TUNEL assay showed that a large number of apoptotic cells, mostl y Schwann cells, were observed in the intratubal and distal nerve segments at weeks 4 and 6 after surgery by the anti -MIF antibody treatment (Fig. 2) . Consistent with these results, immunohistochemical analyses revealed that p53 and, to a lesser extent, Fas were more up-regulated in the anti-MIF antibodytreated nerves than in the controls (Fig. 3) .
DISCUSSION:
As shown in this study, administration of the anti -MIF antibody led to a delay of peripheral nerve regeneration. In a previous study, we showed that MIF mRNA expression was up-regulated after nerve transection, but decreased within three weeks after nerve injury. In this context, it is conceivable that MIF may exert its stimulant effect on nerve regeneration within four weeks after axotomy. Taken together, these findings indicate that MIF may play a pivotal role in the early stages of the peripheral nerve degeneration-regeneration process. Furthermore, we demonstrated that MIF convincingly affected the survival of Schwann cells. Marked apoptosis of Schwann cells was detected in the anti-MIF antibody -treated axotomized nerves. These data strongly suggest that MIF plays a key role not only in peripheral nerve regeneration, but also in viability of Schwann cells by the suppression of apoptosis-related proteins such as p53. The current study may shed light on the novel role of MIF in the nervous system, and could augur therapeutic application of this cytokine to nerve damage. 
